"10.1371_journal.pone.0100370","plos one","2014-06-27T00:00:00Z","Vicky Wang-Wei Tsai; Rakesh Manandhar; Sebastian Beck JÃ¸rgensen; Ka Ki Michelle Lee-Ng; Hong Ping Zhang; Christopher Peter Marquis; Lele Jiang; Yasmin Husaini; Shu Lin; Amanda Sainsbury; Paul E Sawchenko; David A Brown; Samuel N Breit","St Vincent's Centre for Applied Medical Research, St Vincent's Hospital and University of New South Wales, Sydney, New South Wales, Australia; Diabetes Research Unit, Novo Nordisk A/S, Maaloev, Denmark; School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, New South Wales, Australia; Neuroscience Program, Garvan Institute of Medical Research, Sydney, New South Wales, Australia; The Boden Institute of Obesity, Nutrition, Exercise & Eating Disorders, Sydney Medical School, The University of Sydney, New South Wales, Australia; Laboratory of Neuronal Structure and Function, The Salk Institute for Biological Studies, La Jolla, California, United States of America","Conceived and designed the experiments: VWT AS SBJ PES DAB SNB. Performed the experiments: RM KKML HZ CPM. Analyzed the data: VWT. Contributed reagents/materials/analysis tools: CPM DAB SNB. Wrote the paper: VWT AB PES DAB SNB.","The authors have read the journal's policy and have the following conflicts: DAB and SNB are named inventors on patents owned by St Vincent's Hospital that pertain to the clinical use of a MIC-1/GDF15 diagnostic assay and modulatory therapy. SBJ is an employee of Novo NorDisk, which has licensed MIC-1/GDF15 agonist therapeutic technology from St Vincent's Hospital.","2014","06","Vicky Wang-Wei Tsai","VWWT",13,TRUE,6,4,1,5,TRUE,TRUE,TRUE,3,"7;8;9",TRUE
